Front Row Advisors LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Front Row Advisors LLC

  • $277 Million
  • Q4 2024

A detailed history of Front Row Advisors LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Front Row Advisors LLC holds 20 shares of XBI stock, worth $1,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$1,765
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 22, 2023
BUY
$73.13 - $91.97 $1,316 - $1,655
18 Added 900.0%
20 $2,000
Q1 2023

May 15, 2023
SELL
$73.13 - $91.97 $1,316 - $1,655
-18 Reduced 90.0%
2 $2,000
Q1 2020

May 08, 2020
BUY
$65.95 - $98.35 $1,319 - $1,967
20 New
20 $2,000

Others Institutions Holding XBI

# of Institutions
913
Shares Held
102M
Call Options Held
27.4M
Put Options Held
38.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email